Lack of control of hypertension in primary cardiovascular disease prevention in Europe: Results from the EURIKA study

International Journal of Cardiology

Volumn 218, Issue , 2016, Pages 83-88

  Borghi, Claudio ^a   Tubach, Florence ^b,c   De Backer, Guy ^d   Dallongeville, Jean ^e   Guallar, Eliseo ^f,g   Medina, Jesús ^h   Perk, Joep ⁱ   Roy, Carine ^b   Banegas, José R ^j   Rodriguez Artalejo, Fernando ^j   Halcox, Julian P ^k  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b BICHAT HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d GHENT UNIVERSITY   (Belgium)

^e UNIV LILLE   (France)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^h ASTRAZENECA   (United Kingdom)

ⁱ LINNAEUS UNIVERSITY   (Sweden)

^j UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^k SWANSEA UNIVERSITY   (United Kingdom)

more..

Author keywords

Cardiovascular disease; Hypertension; Observational study; Primary prevention; Risk factor

Indexed keywords

URIC ACID;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EUROPE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PRIMARY PREVENTION; PRIORITY JOURNAL; RESISTANT HYPERTENSION; RISK FACTOR; SEX DIFFERENCE; URIC ACID BLOOD LEVEL; AGED; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; MULTICENTER STUDY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRIMARY PREVENTION; RISK FACTORS;

EID: 84969871927     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.05.044     Document Type: Article

References (25)

1. M. Nichols, N. Townsend, P. Scarborough, and et al. European cardiovascular disease statistics Available at: http://www.ehnheart.org/cvd-statistics.html 2012 (Accessed 21 November 2013)
2. J. Perk, G. De Backer, H. Gohlke, and et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur. Heart J. 33 2012 1635 1701
3. F. Rodriguez-Artalejo, E. Guallar, C. Borghi, and et al. Rationale and methods of the European study on cardiovascular risk prevention and management in daily practice (EURIKA) BMC Public Health 10 2010 382
4. J.R. Banegas, E. Lopez-Garcia, J. Dallongeville, and et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study Eur. Heart J. 32 2011 2143 2152
5. J. Dallongeville, J.R. Banegas, F. Tubach, and et al. Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study Eur. J. Cardiovasc. Prev. Rehabil. 19 2011 541 550
6. IMS Health OneKey Available at: http://www.imshealth.com/en/solution-areas/technology-and-applications/offerings/onekey (Accessed 5 February 2016)
7. G. Mancia, R. Fagard, K. Narkiewicz, and et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J. 34 2013 2159 2219
8. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin. Chem. 18 1972 499 502
9. R.M. Conroy, K. Pyorala, A.P. Fitzgerald, and et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur. Heart J. 24 2003 987 1003
10. G. Mancia, G. De Backer, A. Dominiczak, and et al. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J. 28 2007 1462 1536
11. SPRINT Research Group, J.T. Wright Jr., J.D. Williamson, and et al. A randomized trial of intensive versus standard blood-pressure control N. Engl. J. Med. 373 2015 2103 2116
12. K.H. Bonaa, and D.S. Thelle Association between blood pressure and serum lipids in a population. The Tromsø study Circulation 83 1991 1305 1314
13. A.F.G. Cicero, S. D'Addato, M. Veronesi, and et al. Relationship between blood pressure, cholesterolemia and serum apolipoprotein B in a large population sample: the Brisighella heart study J. Hypertens. 30 2012 492 496
14. K. Strehlow, S. Wassmann, M. Bohm, and G. Nickenig Angiotensin AT1 receptor over-expression in hypercholesterolaemia Ann. Med. 32 2000 386 389
15. G. Nickenig, S. Wassmann, and M. Bohm Regulation of the angiotensin AT1 receptor by hypercholesterolaemia Diabetes Obes. Metab. 2 2000 223 228
16. K. Murakami, Y. Uehara, S. Abe, and et al. Positive correlation between chymase-like angiotensin II-forming activity in mononuclear cells and serum cholesterol level J. Cardiol. 50 2007 291 298
17. C. Borghi, M. Veronesi, E. Cosentino, and et al. Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure J. Hypertens. 25 2007 2051 2057
18. Z. Liu The renin-angiotensin system and insulin resistance Curr. Diab. Rep. 7 2007 34 42
19. G. Nickenig, and M. Bohm Interaction between insulin and AT1 receptor. Relevance for hypertension and arteriosclerosis Basic Res. Cardiol. 93 Suppl. 2 1998 135 139
20. G. Nickenig, A.T. Baumer, Y. Temur, D. Kebben, F. Jockenhovel, and M. Bohm Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men Circulation 100 1999 2131 2134
21. R.H. Fagard Resistant hypertension Heart 98 2012 254 261
22. A. de la Sierra, J. Segura, J.R. Banegas, and et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring Hypertension 57 2011 898 902
23. S.L. Daugherty, J.D. Powers, D.J. Magid, and et al. Incidence and prognosis of resistant hypertension in hypertensive patients Circulation 125 2012 1635 1642
24. S.D. Persell Prevalence of resistant hypertension in the United States, 2003-2008 Hypertension 57 2011 1076 1080
25. A. de la Sierra, J.R. Banegas, A. Oliveras, and et al. Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs J. Hypertens. 30 2012 1211 1216